Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study

I Abdollahpour1, S Nedjat2, M A Mansournia3

  • 1Department of Epidemiology, School of Public Health, Arak University of Medical Sciences, Arak, Iran.

Abstract

Insights

Antibiotic use, particularly penicillin and cephalosporins, may decrease the risk of developing multiple sclerosis (MS). However, most viral infections, except infectious mononucleosis, showed no significant association with MS risk.

Area of Science:

  • Neurology
  • Epidemiology
  • Infectious Diseases

Background:

  • Inconclusive evidence exists regarding the role of infections and antibiotic use in multiple sclerosis (MS) etiology.
  • Understanding potential environmental triggers for MS is crucial for prevention and treatment strategies.

Purpose of the Study:

  • To investigate the association between viral infections, antibiotic use, and the risk of developing multiple sclerosis.
  • To clarify the relationship between specific infections and antibiotic classes with MS development.

Main Methods:

  • A population-based incident case-control study was conducted.
  • Data included 547 incident MS cases and 1057 general population controls from Tehran.
  • Multiple logistic regression models were employed to analyze adjusted associations.

Main Results:

  • Antibiotic use for ≥14 days within 3 years prior to the index date was associated with a significantly decreased odds of MS (OR 0.69).
  • Specific antibiotics like penicillin (OR 0.50) and cephalosporins (OR 0.25) showed a significant reduction in MS risk.
  • A history of infectious mononucleosis (IM) was linked to a more than fivefold increased risk of MS (OR 5.7).
  • No significant association was found between other viral infections and MS risk.

Conclusions:

  • Antibiotic use may be associated with a reduced risk of multiple sclerosis, though reverse causation is a possibility.
  • Viral infections, with the exception of infectious mononucleosis, do not appear to be significantly associated with an increased risk of MS.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Antibiotic Selection00:57

Antibiotic Selection

Overview
60.1K
What is Population Genetics?01:25

What is Population Genetics?

A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
475
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
251
What are Populations and Communities?00:30

What are Populations and Communities?

Overview
38.0K